Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: Data from the prospective multicentre NOR-DMARD study

Annals of the Rheumatic Diseases

Volumn 76, Issue 4, 2017, Pages 708-711

  Michelsen, Brigitte ^a,b   Kristianslund, Eirik Klami ^a   Hammer, Hilde Berner ^a   Fagerli, Karen Minde ^a   Lie, Elisabeth ^a   Wierød, Ada ^c   Kalstad, Synøve ^d   Rødevand, Erik ^e   Krøll, Frode ^f   Haugeberg, Glenn ^g,h   Kvien, Tore K ^a  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b Hospital of Southern Norway Kristiansand   (Norway)

^c VESTRE VIKEN HOSPITAL TRUST   (Norway)

^d UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^e TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^f Hospital for Rheumatic Diseases   (Norway)

^g MARTINA HANSENS HOSPITAL   (Norway)

^h NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Disease Activity; Psoriatic Arthritis; Rheumatoid Arthritis; Treatment

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; TUMOR NECROSIS FACTOR INHIBITOR; ANTIRHEUMATIC AGENT; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NORWEGIAN (PEOPLE); PREDICTIVE VALUE; PROSPECTIVE STUDY; PSORIATIC ARTHRITIS; REMISSION; RHEUMATOID ARTHRITIS; SIMPLIFIED DISEASE ACTIVITY INDEX; SMOKING; AGED; ANTAGONISTS AND INHIBITORS; ARTHRALGIA; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; CLINICAL TRIAL; COMPLICATION; DISABILITY; EDEMA; LONGITUDINAL STUDY; MIDDLE AGED; NORWAY; QUESTIONNAIRE; REGISTER; SELF EVALUATION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRALGIA; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; DIAGNOSTIC SELF EVALUATION; DISABILITY EVALUATION; EDEMA; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; METHOTREXATE; MIDDLE AGED; NORWAY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGISTRIES; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84991650660     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2016-210283     Document Type: Article

References (22)

1. Tillett W, Eder L, Goel N, et al. Enhanced patient involvement and the need to revise the core set-report from the psoriatic arthritis working group at OMERACT 2014. J Rheumatol 2015;42:2198-203.
2. van Tuyl LH, Sadlonova M, Davis B, et al. Remission in rheumatoid arthritis: working toward incorporation of the patient perspective at OMERACT 12. J Rheumatol 2016;43:203-7.
3. Heiberg T, Kvien TK. Preferences for improved health examined in 1, 024 patients with rheumatoid arthritis: pain has highest priority. Arthritis Rheum 2002;47:391-7.
4. Gossec L, Smolen JS, Ramiro S, et al. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 2016;75:499-510.
5. Boyden SD, Hossain IN, Wohlfahrt A, et al. Non-inflammatory causes of pain in patients with rheumatoid arthritis. Curr Rheumatol Rep 2016;18:30.
6. Meeus M, Vervisch S, De Clerck LS, et al. Central sensitization in patients with rheumatoid arthritis: A systematic literature review. Semin Arthritis Rheum 2012;41:556-67.
7. Generaal E, Vogelzangs N, Macfarlane GJ, et al. Biological stress systems, adverse life events and the onset of chronic multisite musculoskeletal pain: A 6-year cohort study. Ann Rheum Dis 2016;75:847-54.
8. Goodin BR, Glover TL, Sotolongo A, et al. The association of greater dispositional optimism with less endogenous pain facilitation is indirectly transmitted through lower levels of pain catastrophizing. J Pain 2013;14:126-35.
9. Kristensen LE, Bliddal H, Christensen R, et al. Is swollen to tender joint count ratio a new and useful clinical marker for biologic drug response in rheumatoid arthritis? Results from a Swedish cohort. Arthritis Care Res (Hoboken) 2014;66:173-9.
10. Kvien TK, Heiberg, Lie E, et al. A Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseases. Clin Exp Rheumatol 2005;23:S188-94.
11. Pincus T, Summey JA, Soraci SA Jr, et al. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983;26:1346-53.
12. Wells G, Becker JC, Teng J, et al. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 2009;68:954-60.
13. Aletaha D, Martinez-Avila J, Kvien TK, et al. Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index. Ann Rheum Dis 2012;71:1190-6.
14. Schoels M, Aletaha D, Funovits J, et al. Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis 2010;69:1441-7.
15. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62: 2569-81.
16. Felson DT, Smolen JS, Wells G, et al. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 2011;70:404-13.
17. Salaffi F, Ciapetti A. Disease activity in psoriatic arthritis: comparison of the discriminative capacity and construct validity of six composite indices in a real world. Biomed Res Int 2014;2014:528105. doi:10.1155/2014/528105
18. Schoels MM, Aletaha D, Alasti F, et al. Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Ann Rheum Dis 2016;75:811-18.
19. Pollard LC, Kingsley GH, Choy EH, et al. Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology (Oxford) 2010;49:924-8.
20. Wolfe F, Michaud K, Busch RE, et al. Polysymptomatic distress in patients with rheumatoid arthritis: understanding disproportionate response and its spectrum. Arthritis Care Res (Hoboken) 2014;66:1465-71.
21. Smolen JS, Breedveld FC, Burmester GR, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 2016;75:3-15.
22. Smolen JS, Braun J, Dougados M, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis 2014;73:6-16.